Patent Detecting How Patients Respond to Folate-based Cancer Treatment Approved in the USA

[In The News]

GOTHENBURG, Sweden, Dec. 13, 2019 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announces the approval from the United States Patent and Trademark Office (USPTO) for a patent covering the clinical use of a biomarker analysis to detect cancer...

View the full article